Matches in Wikidata for { <http://www.wikidata.org/entity/Q74631185> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q74631185 description "artículu científicu espublizáu n'agostu de 2002" @default.
- Q74631185 description "im August 2002 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74631185 description "scientific article published on 01 August 2002" @default.
- Q74631185 description "wetenschappelijk artikel" @default.
- Q74631185 description "наукова стаття, опублікована в серпні 2002" @default.
- Q74631185 name "Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): from the results of phase I and phase II clinical trials" @default.
- Q74631185 name "Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140" @default.
- Q74631185 type Item @default.
- Q74631185 label "Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): from the results of phase I and phase II clinical trials" @default.
- Q74631185 label "Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140" @default.
- Q74631185 prefLabel "Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): from the results of phase I and phase II clinical trials" @default.
- Q74631185 prefLabel "Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140" @default.
- Q74631185 P1433 Q74631185-5470976B-BEDF-487C-B769-8229D16DE928 @default.
- Q74631185 P1476 Q74631185-816178C1-B4B1-4894-BAEB-BDFACFD3ACDB @default.
- Q74631185 P2093 Q74631185-212B06BF-0A6C-40FD-804B-05D7F8A7A91D @default.
- Q74631185 P2093 Q74631185-3B67C066-58F6-4FC8-9C08-6E645F9A39E8 @default.
- Q74631185 P2093 Q74631185-5AA98E4B-9AF4-4DF2-A1DC-A2E030B15E04 @default.
- Q74631185 P2093 Q74631185-8A5DBBB1-C39D-4364-BC17-1680A35F5010 @default.
- Q74631185 P2093 Q74631185-F10F0E2E-127F-488E-9000-A286BF1F6178 @default.
- Q74631185 P2093 Q74631185-FD0C132A-4640-4A69-B06B-59069532C142 @default.
- Q74631185 P304 Q74631185-34417314-BC4B-477B-8591-796F643000A7 @default.
- Q74631185 P31 Q74631185-305F93F6-45AD-4EAA-88CA-9CFF8A8DEFE8 @default.
- Q74631185 P356 Q74631185-EDCBC131-D03D-4BDE-8186-202ECC9F35B3 @default.
- Q74631185 P478 Q74631185-E83FC947-D562-46DE-894D-5A103D18EECC @default.
- Q74631185 P577 Q74631185-54C30A3F-E5F2-4C7B-A7C6-6A91524D61F2 @default.
- Q74631185 P698 Q74631185-736CC56B-F189-476B-8800-1B3CE4265271 @default.
- Q74631185 P921 Q74631185-152FF022-E8D6-45B9-B0D7-B890E2E8A5C7 @default.
- Q74631185 P921 Q74631185-6C5C6B27-879A-49D5-A481-B4EB52ACC5DD @default.
- Q74631185 P921 Q74631185-B2DDCE7C-EE88-4D54-BE90-5847729DC46C @default.
- Q74631185 P356 S1076-6332(03)80262-3 @default.
- Q74631185 P698 12188307 @default.
- Q74631185 P1433 Q15755259 @default.
- Q74631185 P1476 "Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): from the results of phase I and phase II clinical trials" @default.
- Q74631185 P2093 "Akihiro Tanimoto" @default.
- Q74631185 P2093 "Masumi Kadoya" @default.
- Q74631185 P2093 "Ryohei Kuwatsuru" @default.
- Q74631185 P2093 "Shinji Hirohashi" @default.
- Q74631185 P2093 "Takehiko Gokan" @default.
- Q74631185 P2093 "Yasutaka Kawamura" @default.
- Q74631185 P304 "S457-9" @default.
- Q74631185 P31 Q13442814 @default.
- Q74631185 P356 "10.1016/S1076-6332(03)80262-3" @default.
- Q74631185 P478 "9 Suppl 2" @default.
- Q74631185 P577 "2002-08-01T00:00:00Z" @default.
- Q74631185 P698 "12188307" @default.
- Q74631185 P921 Q42824440 @default.
- Q74631185 P921 Q5452194 @default.
- Q74631185 P921 Q6849688 @default.